COMPLIX NV - Belgium 

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2014-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2015 0 3.849.088 0 1
2014 0 1.234.000 344.599 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS LEIDEN1
AICURIS GMBH & CO KG1
AMAKEM NV1
ARATANA THERAPEUTICS NV1
COMPLIX LUXEMBOURG1
FAST FORWARD PHARMACEUTICALS BV1
FOUNDATION BIOMEDICAL PRIMATE RESEARCH CENTRE1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
KATHOLIEKE UNIVERSITEIT LEUVEN1
MINDNRG1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITAT WIEN1
UNIVERSITE D'AIX MARSEILLE1
UNIVERSITEIT UTRECHT1
UNIVERSITY OF WALES CARDIFF1
VIROVET BVBA1

Constancy:

Total number of partners: 16
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 16
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2015-03-01European Training Network on Antiviral Drug Development ANTIVIRALSparticipant3.849.08812
2014-01-01Use of PRIMate MOdels to support translational MEDicine and advance disease modifying therapies for unmet medical needs PRIMOMEDparticipant1.234.0006